[HTML][HTML] Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
The sudden emergence of severe respiratory disease, caused by a novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently become a public health …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently become a public health …
Drug repurposing approach to fight COVID-19
Currently, there are no treatment options available for the deadly contagious disease,
coronavirus disease 2019 (COVID-19). Drug repurposing is a process of identifying new …
coronavirus disease 2019 (COVID-19). Drug repurposing is a process of identifying new …
Candidate drugs against SARS-CoV-2 and COVID-19
DL McKee, A Sternberg, U Stange, S Laufer… - Pharmacological …, 2020 - Elsevier
Outbreak and pandemic of coronavirus SARS-CoV-2 in 2019/2020 will challenge global
health for the future. Because a vaccine against the virus will not be available in the near …
health for the future. Because a vaccine against the virus will not be available in the near …
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
L Yang, Z Wang - European Journal of Medicinal Chemistry, 2023 - Elsevier
The ongoing COVID-19 pandemic has resulted in millions of deaths globally, highlighting
the need to develop potent prophylactic and therapeutic strategies against SARS-CoV-2 …
the need to develop potent prophylactic and therapeutic strategies against SARS-CoV-2 …
[HTML][HTML] Traditional Chinese medicine in COVID-19
M Lyu, G Fan, G Xiao, T Wang, D Xu, J Gao… - … Pharmaceutica Sinica B, 2021 - Elsevier
COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has spread across the globe, posing an enormous threat to public health and safety …
CoV-2) has spread across the globe, posing an enormous threat to public health and safety …
The human coronavirus disease COVID-19: its origin, characteristics, and insights into potential drugs and its mechanisms
The emerging coronavirus disease (COVID-19) swept across the world, affecting more than
200 countries and territories. Genomic analysis suggests that the COVID-19 virus originated …
200 countries and territories. Genomic analysis suggests that the COVID-19 virus originated …
Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern …
Molnupiravir and its antiviral activity against COVID-19
L Tian, Z Pang, M Li, F Lou, X An, S Zhu… - Frontiers in …, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) constitutes a major worldwide public health threat …
syndrome coronavirus 2 (SARS-CoV-2) constitutes a major worldwide public health threat …
[HTML][HTML] In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
Background The rapidly enlarging COVID-19 pandemic caused by the novel SARS-corona
virus-2 is a global public health emergency of an unprecedented level. Unfortunately no …
virus-2 is a global public health emergency of an unprecedented level. Unfortunately no …
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
In December 2019, a novel SARS-CoV-2 coronavirus emerged, causing an outbreak of life-
threatening pneumonia in the Hubei province, China, and has now spread worldwide …
threatening pneumonia in the Hubei province, China, and has now spread worldwide …